Skip to content
10-K

Annual Report

THC THERAPEUTICS, INC.

0001477932-22-008875

← back to feed
Filed
Nov 25, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Nov 21, 2022 34.15M sh
Cash And Equivalents FY 2022 · Jul 31, 2022 $32
Cash And Equivalents FY 2022 · Jul 31, 2021 $296.13K
Eps Basic FY 2022 · Jul 31, 2022 −$0.05
Eps Basic FY 2022 · Jul 31, 2021 −$0.08
Sga Expense FY 2022 · Jul 31, 2022 $138.28K
Sga Expense FY 2022 · Jul 31, 2021 $212.99K
Stock Repurchased FY 2022 · Jul 31, 2021 $0
Operating Cash Flow FY 2022 · Jul 31, 2021 −$388.48K
Current Liabilities FY 2022 · Jul 31, 2021 $2.86M
Total Liabilities FY 2022 · Jul 31, 2021 $2.86M
Current Assets FY 2022 · Jul 31, 2021 $301.55K
Total Assets FY 2022 · Jul 31, 2021 $480.07K
Net Income FY 2022 · Jul 31, 2021 −$1.89M
Operating Income FY 2022 · Jul 31, 2021 −$939.98K
Gross Profit FY 2022 · Jul 31, 2021 $0
Cost Of Revenue FY 2022 · Jul 31, 2021 $0
Revenue FY 2022 · Jul 31, 2021 $0
Stockholders Equity restated FY 2022 · Jul 31, 2020 −$1.74M